These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8958039)

  • 1. A glimpse of the future. new directions in the treatment of colorectal cancer.
    Van Cutsem E
    Eur J Cancer; 1996; 32A Suppl 5():S23-7. PubMed ID: 8958039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuing the fight against advanced colorectal cancer: new and future treatment options.
    Bleiberg H
    Anticancer Drugs; 1998 Jan; 9(1):18-28. PubMed ID: 9491788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mature results from three large controlled studies with raltitrexed ('Tomudex').
    Cunningham D
    Br J Cancer; 1998; 77 Suppl 2(Suppl 2):15-21. PubMed ID: 9579851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Tomudex' (ZD1694): a novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. 'Tomudex' International Study Group.
    Cunningham D; Zalcberg J; Smith I; Gore M; Pazdur R; Burris H; Meropol NJ; Kennealey G; Seymour L
    Ann Oncol; 1996 Feb; 7(2):179-82. PubMed ID: 8777175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase I inhibitors in the treatment of colorectal cancer.
    Rothenberg ML; Blanke CD
    Semin Oncol; 1999 Dec; 26(6):632-9. PubMed ID: 10606256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status.
    Papamichael D
    Oncologist; 1999; 4(6):478-87. PubMed ID: 10631692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed ('Tomudex').
    Blackledge G
    Br J Cancer; 1998; 77 Suppl 2(Suppl 2):29-37. PubMed ID: 9579853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer: the challenge.
    Bleiberg H
    Eur J Cancer; 1996; 32A Suppl 5():S2-6. PubMed ID: 8958035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors.
    Rustum YM; Harstrick A; Cao S; Vanhoefer U; Yin MB; Wilke H; Seeber S
    J Clin Oncol; 1997 Jan; 15(1):389-400. PubMed ID: 8996166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent advance in chemotherapy for advanced colorectal cancer].
    Aiba K
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):535-48. PubMed ID: 8678510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The medical treatment of colorectal cancer: actual status and new developments.
    Van Cutsem E; Peeters M; Verslype C; Filez L; Haustermans K; Janssens J
    Hepatogastroenterology; 1999; 46(26):709-16. PubMed ID: 10370599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status.
    Papamichael D
    Stem Cells; 2000; 18(3):166-75. PubMed ID: 10840069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs in the treatment of colorectal carcinoma.
    Punt CJ
    Cancer; 1998 Aug; 83(4):679-89. PubMed ID: 9708931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study Group.
    Cunningham D; Zalcberg JR; Rath U; Olver I; Van Cutsem E; Svensson C; Seitz JF; Harper P; Kerr D; Perez-Manga G
    Eur J Cancer; 1995 Nov; 31A(12):1945-54. PubMed ID: 8562146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: prospects and future directions.
    Schmoll HJ
    Semin Oncol; 2002 Oct; 29(5 Suppl 15):34-9. PubMed ID: 12422306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting.
    Folprecht G; Köhne CH
    Nat Clin Pract Oncol; 2005 Nov; 2(11):578-87. PubMed ID: 16270098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthase: a target for combination therapy and determinant of chemotherapeutic response in colorectal cancer.
    Van Triest B; Peters GJ
    Oncology; 1999 Oct; 57(3):179-94. PubMed ID: 10545786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulated 5-fluorouracil (5-FU) regimens in advanced colorectal cancer: a critical review of comparative studies.
    Labianca R; Pessi A; Facendola G; Pirovano M; Luporini G
    Eur J Cancer; 1996; 32A Suppl 5():S7-12. PubMed ID: 8958036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma].
    Bokemeyer C; Hartmann JT; Kanz L
    Praxis (Bern 1994); 1997 Sep; 86(39):1510-6. PubMed ID: 9411671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on new chemotherapeutic agents in the treatment of colorectal cancer.
    Clark JW
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-19-S18-24. PubMed ID: 9420017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.